• Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Whanin Pharmaceutical Co Ltd

+ Add to Watchlist

016580:KS

21,800 KRW 200 0.91%

As of 01:12:02 ET on 12/26/2014.

Snapshot for Whanin Pharmaceutical Co Ltd (016580)

Open: 22,250 Day's Range: 21,750 - 22,250 Volume: 24,273
Previous Close: 22,000 52wk Range: 10,300 - 28,100 1-Yr Rtn: +110.47%

Stock Chart for 016580

No chart data available.
  • 016580:KS 21,800
  • 1D
  • 1M
  • 1Y
22,000
Interactive 016580 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 016580

Current P/E Ratio (ttm) 18.2274
Estimated P/E(-) -
Relative P/E vs. KOSPI 0.6615
Earnings Per Share (ttm) 1,196.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 405,481.53
Shares Outstanding (M) 18.60
30 Day Average Volume 51,002
Price/Book (mrq) 1.8084
Price/Sale (ttm) 2.8441
Dividend Indicated Gross Yield 1.15%
Cash Dividend (KRW) 250.0000
Dividend Ex-Date 12/27/2013
5 Year Dividend Growth 4.56%
Next Earnings Announcement 02/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 016580

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 016580

Whanin Pharmaceutical Co., Ltd. manufactures medical drugs. The Company produces medicines used to treat mental disorder, fever, liver disorder, and alcohol addiction. Whanin Pharmaceutical also produces antibiotics and multi-vitamins.

Lee Kwang-SikChairman/CEO/Co-Rep DirectorLee Won-BeomPresident/Co-Rep Director
Kim Chong-SuVice PresidentAhn Byeong-LakSenior Managing Director
More Company Profile & Key Executives for 016580

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil